(RTTNews) - Viking Therapeutics, Inc. (VKTX) Tuesday reported positive 52-week histologic data from its Phase 2b VOYAGE study of VK2809 in patients with non-alcoholic steatohepatitis (NASH).

Weight loss drug developer Viking Therapeutics (NASDAQ:VKTX) traded higher premarket Tuesday after announcing 52-week data from a mid-stage trial for VK2809 targeted at the liver disorder ...

Extending the farthest out it ever has, the global cruise ship orderbook now includes a total of 62 ships entering service ...

Jefferson will also receive a signing bonus of $88.743 million, the highest for a non-quarterback in league history. ...

Viking Therapeutics (NASDAQ:VKTX) stock rose 5%, with the biotech company benefiting from the news that the institutional ...

Viking starts third season in the Great Lakes, with both of its identical expedition ships, the Viking Octantis and ...

Justin has earned this contract, and we are thrilled he will remain a Minnesota Viking for a very long time.” General Manager ...

STOCKHOLM, June 4, 2024 /PRNewswire/ -- CheckProof, a Swedish SaaS company, is thrilled to announce a significant investment and long-term partnership with Viking Venture, the leading Nordic B2B ...

Vikings owners Mark and Zygi Wilf said in a statement that Jefferson has “earned this contract, and we are thrilled he will remain a Minnesota Viking for a very long time.” Vikings general manager ...

In the early 1950’s, Pat and Buzz started Viking Import House in Dayton, Ohio, a business that specialized in importing Danish Christmas plates and other collectibles. Because of their love of the ...

Vikings receiver Justin Jefferson will be the highest-pain non-quarterback in the NFL, averaging $35 million per season, ...

Discover 19 fun and kid-friendly activities in Dublin that guarantee an unforgettable family trip! Explore the best ...